The role and future challenges for recombinant growth hormone therapy to promote growth in children after renal transplantation

Halima S. Janjua, John D. Mahan

Research output: Contribution to journalReview articlepeer-review

Abstract

Chronic kidney disease can severely impair linear growth in children. For many children, growth improves after renal transplantation, but for some, growth velocity remains low and for others, catch-up growth is insufficient to compensate for the deficit imparted by renal disease in the preceding years. Inadequate final adult height after renal transplant is multifactorial and can adversely affect the quality of life (QOL), psychosocial development and long term prospects for these children as they grow into adulthood. Growth failure after renal transplant requires thorough evaluation and its management in renal transplant recipients can involve improved nutritional intake, correction of metabolic acidosis, treatment of secondary hyperparathyroidism, steroid-sparing immunosuppression and/or use of recombinant human growth hormone (rGH). Treatment with rGH after renal transplant has been evaluated by a limited number of clinical trials suggesting efficacy and safety for this treatment strategy. Several important clinical questions regarding rGH use in children post-renal transplant remain unanswered.

Original languageEnglish (US)
Pages (from-to)E469-E474
JournalClinical Transplantation
Volume25
Issue number5
DOIs
StatePublished - Sep 2011
Externally publishedYes

Keywords

  • Kidney disease
  • Management
  • Pathophysiology
  • Quality of life
  • Short stature

ASJC Scopus subject areas

  • Transplantation

Fingerprint

Dive into the research topics of 'The role and future challenges for recombinant growth hormone therapy to promote growth in children after renal transplantation'. Together they form a unique fingerprint.

Cite this